Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.82
+0.03 (0.07%)
Dec 24, 2024, 4:00 PM EST - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.64 billion as of December 24, 2024. Its market cap has increased by 107.15% in one year.
Market Cap
2.64B
Enterprise Value
1.82B
1-Year Change
107.15%
Ranking
Category
Stock Price
$40.82
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.64B, an increase of 216.81%. That is a compound annual growth rate of 30.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 2.64B | 87.00% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patterson Companies | 2.72B |
| Vera Therapeutics | 2.68B |
| Apogee Therapeutics | 2.67B |
| Surgery Partners | 2.64B |
| Neogen | 2.62B |
| Concentra Group Holdings Parent | 2.58B |
| Catalyst Pharmaceuticals | 2.57B |
| HUTCHMED (China) | 2.55B |